KalVista Pharmaceuticals, Inc.
KALV
$11.70
-$0.05-0.43%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/3/2025
-
GuruFocus
10/3/2025
-
Business Wire
10/3/2025
-
Tickeron - Stocks
10/2/2025
-
GuruFocus
10/2/2025
-
Business Wire
10/1/2025
-
MarketBeat
9/27/2025
-
Tickeron - Stocks
9/26/2025
-
Stock Options Channel
9/26/2025
-
Business Wire
9/26/2025
-
Tickeron - Technical Analysis
9/25/2025
-
Stock Options Channel
9/25/2025
-
MarketBeat
9/25/2025
-
Market News Video
9/25/2025
-
Business Wire
9/24/2025
-
GuruFocus
9/24/2025
-
Business Wire
9/19/2025
-
Stocktwits News Feed
9/19/2025
-
Business Wire
9/18/2025
-
ETF Channel
9/17/2025
-
Tickeron - Stocks
9/15/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/14/2025
-
MarketBeat
9/13/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, September 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Dec 1 and 5 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 999 0075
Address
55 Cambridge Parkway
Cambridge, MA 02142
Cambridge, MA 02142
Country
Year Founded
--
Business Description
Sector
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company’s...
more